Canakinumab Subcutaneous and Iloprost inhalation

• Generic Name: canakinumab
• Dosage Forms: n.a.
• Other Brand Names: Ilaris

Canakinumab injection is used to treat cryopyrin-associated periodic syndromes (CAPS). This also includes familial cold auto-inflammatory syndrome (FCAS) and Muckle-Wells syndrome (MWS). CAPS is a rare, inherited disease of the immune system. It occurs when the body produces too much of a chemical called interleukin-1 beta. This chemical causes inflammation, and patients with CAPS may have a fever, headache, skin rash, joint or muscle pain, or unusual tiredness or weakness.

Canakinumab helps prevent inflammation by keeping the interleukin-1 beta from working properly. Canakinumab also treats adults and children with other autoinflammatory periodic fever syndromes, such as tumor necrosis factor receptor associated periodic syndrome (TRAPS), hyperimmunoglobulin D syndrome (HIDS)/mevalonate kinase deficiency (MKD), and familial Mediterranean fever (FMF).

Canakinumab is also used to treat active systemic juvenile idiopathic arthritis (SJIA) in children 2 years of age and older.

Canakinumab is to be given only by or under the direct supervision of a doctor.

• Generic Name: iloprost
• Dosage Forms: n.a.
• Other Brand Names: Ventavis

Iloprost inhalation is an synthetic prostacyclin. It works by opening blood vessels in the lungs.

Iloprost inhalation is used to treat pulmonary arterial hypertension (PAH). It decreases symptoms of this condition and improves your ability to exercise.

Iloprost inhalation may also be used for purposes not listed in this medication guide.